Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hail, .....I'll even go one better. "..IF.." you personally have $5000 cash that you can truly 'afford & enjoy' throwing off the back of a riverboat casino for the sheer joy of seeing it flutter in the wind - then BUY-BUY-BUY BFHJ today..!!! "..Tee hee....
Otherwise, I suggest you follow my more reasonable, unemotional advice and buy when Mgmt follows through on some of its 'smoke signals'.
.
Show me a post where I said "..scam.."!!! . Typical word-twisting in support of poor logic.
My advice is to hold a large bag of dry powder, and BUY when you see BFHJ quit 'talking' and start 'doing' on OTCMarkets.com - and/or an OTCBB.com advisory of an UPLIST..!!!
So did the USSR, but those who failed to follow the rules failed a whole lot sooner.
If you feel my advice is in question, please buy a book on Penny Stock Investing by someone you respect and see if their advice is much different. One of the major rules is 'don't get emotionally involved'; ...clearly a major poster attribute on this Board.
.
Cute. . Responsibility and rationality = 'propaganda' to you ..!?! . Is your middle name Goebbels, per chance..??? Ha ha ha ha ha ha ha ha ha....................
Long, Holding, Waiting for responsible Mgmt reporting behavior.......
.
"..When in Rome, do as the Romans do......... When you're on the Pinks, make the Pink reports. When you're on the OTCBB, make the OTCBB reports. When your on NAZ, AMEX or NYSE, make the appropriate reports and keep your PPS above the minimums. You don't say, "..I ain't gonna play.." because you have an ego that won't let you deal with the truth of the current situation..!!!
BFHJ Mgmt apparently thinks they are bigger than the system - and they aren't. They are a PUBLIC BUSINESS - and they need to comply with the station they find themselves in.
.
Hey, if the truth hurts and you want to call it bashing - 'C'est la guerre....
If BFHJ Management wants to avoid a 10 minute phone call to OTCMArkets.com, and can't find 1/2-day of secretary time to get their info faxed or emailed to OTCM - then I'll hammer their arse until the day they do..!!! And, I'm 100% justified in doing so..!!!
The "..Rah rah zis boom bah..", "..slap the Ask..", and Little Orphan Annie "..Tomorrow, tomorrow, there's always tomorrow.." posts are the detrimental information here that plays right into the MFMMMs and B-Ds hands.
Long, Holding, Will accumulate more on OTCMarkets condition fix..!!!
.
BS walks, filings talk....................
.
For those who "..just don't get it.."; here is PINKS-101: . If a company has all it's reports or available info in order, and there is no STOP SIGN or other negative crap on OTCMarkets.com then they are (almost) a believable entity.
If there is NO NEGATIVE INFO on OTCMarkets.com, the Attorney/Agent has a real phone number/address and will answer same, and PR's contain some viable, verifiable FACTS, then the SEC just might pay attention when investor complaints come in showing the the SCURRILOUS MFMMMs, SLIME-SUCKING BROKER-DEALERS, and INSIDE TRADERS/SHORTERS are manipulating the stock price and failing to deliver (FTD) on naked shorts as required by law..!!!
Under the current conditons, the agent at the SEC with take another bite of his bean sprout sandwich and forget you 2 seconds after you hang up - or throw your online (w)itch email in the circular file. Sorry, ...but I can't quite reach you with my 2x4. You'll just have to learn this the hard way, or learn to comprehend what you read from people with 13+ years trading in these manipulable sub-micros.
.
That kind of logic is what screws up this market. . If I moved in next door to you, joined the Country Club, became a Scout Master, tithed at Church, and shoveled two little ol' ladies driveways with my snow blower everyone would like that. YET, ....If let the weeds grow 4' tall, parked no-wheel rusted cars on my lawn and driveway, and walked around in the nude with my curtains open - you'd call the Cops or the Zoning police on me.
Same poop - different day, BFHJ is not doing jack crap about WHAT THEY'RE SUPPOSED TO BE DOING - keeping OTCMarkets.com and the SEC up to speed. Not too mention the USA Agent/Attorney has a phony address..!!! And, nobody east of the Mississippi (aka: The Street) gives a rat's tush what the AZ Secretary of State has to say - since that info can change radically overnight to the gross negative. Also, companies in that banana republic of Nicaragua can be NATIONALIZED by the commies - overnight..!!!
Get freaking real. DEMAND GOOD BUSINESS PRACTICES from BFHJ Management - not more and incessant PR or phone leak BS..!!!
.
S-O-S; different freakin' day..!!! Long term the PPS will trend up and down in spits, spurts and beatdowns. BFHJ is currently just another pink ping pong ball for the MFMMMs greed games, B/Ds and non-posting day traders to play with. The only thing that is going to change all this is for the thumb-bouncing management to get off their round ends and CLEAR UP THE MESS ON PINKSHEETS.COM, FILE THE ATTORNEY"S OPINION LETTER, FILE THE MINIMAL DAM* FINANCIALS, AND HAVE THEIR FAVORITE MFMMM FILE FOR AN OTCQB UPLIST..!!!
No "responsible investor" or Institution is going to put $0.05 into BFHJ until the company shows responsibility in the area of transparency. Any broker at a responsible brokerage who currently Reco's BFHJ to a client would probably be subject to dismissal. As with Acedemia, it's "publish (the truth) or perish" for management - or twist in the wind until you do.
(Long, Patient); but grossly tired of the BS here. . If you really give a rat's tush about making big gains, call-write-email BFHJ management and demand that they get their SEC poop in a group. If you own the stock, then it's your company too. . Do your job by seeing that management does theirs.
.
Considering how long you've been around, you should know that 5000 & 1000 are B-A setting MFMMM no-trade inputs and that 100 through 900 size trades are MFMMM 'signals' to shuffle shares among them. Trades under 1000 on penny stocks are 99% all MFMMM BS trades as the commission for a retail customer would usually exceed the value of the purchase or sale.
Let's try to keep it real.... (Long, Holding).
.
Correction: I subsequently cross-checked with the HQ who gave me the current status:
A/S = 1.5B shares.
The other information on OTCMarkets.com is as shown.
.
Wierd. 15:37:52 - some 'ijit' either put in a Market Order and got burned for 0.042, or the MFMMMs dropped the B-A and allowed one of their goombahs to buy 20K at that price. The Bid bounced down to 0.042 for about 10 seconds for that trade, and then racked right back up to 0.045 again.
0.044 10000 OTO 15:50:03
0.044 21637 OTO 15:45:21
0.044 5000 OTO 15:44:28
0.045 5000 OTO 15:41:50
0.0461 11843 OTO 15:41:27
0.045 30000 OTO 15:39:25
0.042 20000 OTO 15:37:52
0.044 10000 OTO 15:37:33
0.044 5300 OTO 15:27:56
Now the MFMMMs are jacking the B-A around again as the dayplayers are getting out for the weekend. What a trip. Some real substantial street News or PR should have some very positive effects based on the trading; FMPOV.
.
Per a conversation with the Transfer Agent this morning,
O/S = 636MM+/-
A/S = 750MM (only 1/2 that shown on OTCMarkets.com)
A friend of mine waited almost 20 minutes yesterday to get a "Market Order" filled. This would tend to show things are getting tight and perhaps the MFMMMs are still trying to feed to hedge fund orders at the lowest possible prices with a little B-A jacking (IMHO).
.
Whispers come from old friends in advantageous places who perhaps frequent the same restaurants or pubs, etc., with the Streeters or other folks of note. Like a reporter, one uses discretion and weighs or verifies such info as appropriate.
.
Viral Genetics, Inc. Interim Report
On December 29, 2010 the Company entered into a binding Release and Settlement
Agreement (the “Settlement”) with Timothy and Thomas, LLC (“T&T”), and its
principals, Thomas J. Little and Timothy W. Wright, III. Haig Keledjian, our President
and a principal stockholder of the Company, was also party to the agreement. The
Settlement, which is effective as of October 19, 2010, was filed with and approved by
United States District Court for the Northern District of Illinois. The Settlement itself is
subject to a confidentiality ruling by the court.
As a result of the Settlement, T&T’s complaint (as amended) against the Company and
Haig Keledjian, and our counter-complaint (as amended) against T&T and its principals,
were dismissed without admission of liability by any party, effectively ending the
litigation that began in March 2006.
As part of the Settlement, we terminated the Distribution Management Agreement (the
“DMA”) between us and T&T, effectively reacquiring the rights to develop and market
HIV/AIDS products in Africa. The DMA had granted these rights to T&T for a period of
twenty years. In consideration for the termination of the DMA, we agreed to pay to T&T
over the course of three years a total of $1,900,000 as follows: $1,000,000 by November
1, 2011; $450,000 by November 1, 2012; and $450,000 by November 1, 2013. These
installments are secured by and will be paid under a Convertible Debenture (the
“Debenture”).
Under the Debenture and subject to certain terms and conditions, at our option we can
elect to make these installment payments in cash or in shares of common stock. The
conversion price for a payment in shares is equal to the 20-trading day volume-weighted
average closing price of the shares for the period ending the day prior to each installment
due date, not to exceed $0.15. Further, if the Company’s common shares trade at or
above $0.20, the option to receive payment in shares or cash shall be at T&T’s discretion.
We may also prepay all or any part of the Debenture in cash or stock at any time without
penalty, provided that we can only prepay in stock under certain terms and conditions
including that the shares are either registered for resale or may be sold under an
exemption from registration. We can also direct T&T to assign all or any part of the
Debenture to a third party for cash at any time. The Debenture ranks junior in security to
the note held by Best Investments, Inc. (controlled by Haig Keledjian, our President), but
will rank senior to any subsequent debt issued by the Company. Unpaid principal and
interest under the Debenture is accelerated under certain terms and conditions.
.
There's a helluva lot of green indicators on Barcharts.com:
http://www.barchart.com/opinions/stocks/VRAL
The 3 mo. chart shows accumulation and increasing volume:
IMHO, VRAL is 9.1 months pregnant. So, I hope everyone fueled up their Bugatti Veyrons yesterday. There are whispers of a serious hedge fund buying blocks and doing a 'Blue Horseshoe loves VRAL' subscriber advisory after their best nitpicking techies tore into the Who's Who and What's What of the company.
.
The way I hear it, the MFMMMs are jacking the B-A to cover up the accumulation by big players re: pending VG Energy news.
I'm green, and collecting on all the dips.
.
Why don't you check my previous posts, where position was clearly stated.
ACTT has a fiduciary responsibility to protect the value of all share holders stock; sitting on their round ends acting like NAZ snobs is not doing that. They are Pink, and they need to deal with Pink matters until they move back to higher levels. Especially when stockholders contact them and hand them the solution on a plate.
The current OTCMkt ratings makes them look like stock manipulation crooks. That makes me very displeased - whether you and Mz Kitty like it or not..!!!
.
I'm the person who got it started on Monday early..!!!! Contact by the company to OTCMkts could have resolved it by now; all it takes is a call and a fax or two.
Salaried HQ Thumbbouncers whiz me off, when they have been multiply advised - and do nothing......
.
Nothing done yet to get rid of CAVEAT EMPTOR rating on OTCMarkets.com. Obviously the powers at be don't think that looking like other Pink scammers companies is an important disservice to investors. http://www.otcmarkets.com/stock/ACTT/quote
I'm whizzed considering efforts expended to try and get the point across to apparently dead ears.
.
VRAL - suggest putting on watch list and accumulating on dips.
.
VRAL - picked up more at dip to 0.044.
Suggest DD promptly; biotech / HIV / bioenergy (algae/lipids).
.
VRAL could be huge potential winner, DD ASAP:
Viral Genetics Issues 2010 Year in Review, 2011 Outlook
Viral Genetics (USOTC:VRAL)
Intraday Stock Chart
Today : Thursday 3 February 2011
Click Here for more Viral Genetics Charts.
Viral Genetics (Pink Sheets: VRAL) ("the Company") has released its 2010 Year in Review and 2011 Outlook by CEO Haig Keledjian. The following is a brief summary of that report. A copy of the full 14-page report is now available on the company website (www.viralgenetics.com). Additionally, the company has now added two comprehensive research reports available on the website by Zacks Equity Research and Research 2.0. In 2010 the Company moved closer to its goal of bringing new drugs to market by positioning itself for the significant step of advancing the clinical trial process in 2011. The Company expanded its research facilities and capabilities and is looking forward to gathering data from potential drug therapies using its patented Metabolic Disruption Technology (MDT) and Targeted Peptide Technology (TPT). New data sources include an investigator study of MDT therapies for drug-resistant cancers at Scott and White Hospital this spring, funded in part by a recent $1.5 million anonymous grant to the hospital.
"Progress throughout the past year has brought us closer to fulfilling our mission of bringing new drug therapies to the marketplace," notes Viral Genetics CEO Haig Keledjian in the review. "In 2010 we made concrete, measurable steps towards that goal, while also expanding our research to include the development of biofuel technologies through our new subsidiary, VG Energy. We're well positioned to execute against our business objectives in 2011."
Viral Genetics' patents and proprietary technology are being developed in collaboration with several Texas A&M University researchers and support from the State of Texas. Last year, the Company's lead scientist, Dr. M. Karen Newell Rogers, joined the faculty at Texas A&M University Health Science Center's College of Medicine and the Department of Surgery, Scott and White Hospital in Temple, Texas. Now located in a hospital environment and surrounded by leading clinicians, Dr. Newell Rogers has access to significantly enhanced resources for transitioning her research from the lab to patients in the clinic. Additionally, she was awarded a $750,000 grant from the Texas Emerging Technologies Fund to research biofuels, which enabled the opening of a new research facility in Georgetown, Texas. In parallel, the Company expanded its research team and brought on specialized staff, in part to assist in the regulatory process with the U.S. Food and Drug Administration (FDA).
HIV/AIDS Program
The Company in 2010 submitted to the FDA a pre-IND (Investigational New Drug) letter for its Targeted Peptide HIV/AIDS compound, APi1177 (also known as VGV-X when in injectable form). The FDA issued a pre-IND number and a date in the first quarter of 2011 to meet with the agency for a formal review of the drug's development path and to present the plan for US trials. A "pre-IND meeting" precedes a full Investigational New Drug application and typically requires additional preclinical studies, but provides comments and feedback from the FDA that will essentially facilitate a blueprint for Viral Genetics' researchers to follow in developing the drug.
Oncology Programs
Building on the successes of 2010, researchers at Scott and White Hospital anticipate initiating clinical trials in 2011 to treat "treatment refractory" patients with drug-resistant forms of skin, ovarian, breast, and other cancers under investigator INDs for Viral Genetics' MDT compounds. An "investigator study" is one in which a physician directly asks the FDA for permission to use experimental drug compounds on patients that generally are considered to have limited treatment options. The principle investigator on the initiative is Ed Childs, M.D., with Juan Posada, M.D., serving as the lead oncologist and co-investigator. The compounds being studied in these trials are combinations of drugs or other compounds that, individually, are already approved by the FDA for non-cancer indications, but will be used in combination with standard cancer treatments with the goal of enhancing overall effectiveness in shrinking or eliminating tumors. Viral Genetics' intellectual property in this area protects the actual compounds and combinations of compounds for use in cancer therapy, as well as the underlying methods targeting the mechanism of action.
Potential Applications in Biofuels
Dr. Newell Rogers' work in 2010 with MDT, used to target the unique metabolic demands of tumor cells, has also shown potential in modifying the metabolic strategy of algae and plants through the same underlying mechanism, thus creating a new approach for improving the yield of biofuels including raising algae oil yields in pilot studies by 300%. The promise of this technology prompted Viral Genetics to form VG Energy, Inc. to further develop and potentially market biofuel technology. A working preliminary note examining this technology by new advisor and biofuels expert, John Sheehan, is available on the VG Energy website (www.vgenergy.net).
Legal Settlement
On January 3, 2011, Viral Genetics settled the nearly 5 year-old lawsuit that was before the U. S. District Court for the Northern District of Illinois (No. 06 C 1813) regarding the Company's previous efforts in South Africa. This settlement frees up management time and Company resources that were previously consumed by the expensive litigation process and it allows Viral Genetics to continue the pursuit of the registration of an HIV/AIDS drug in Africa – the single largest potential market for such a product. See the Company's January 28, 2011 press release for more information.
Enhanced Advisory Board
Several notable advisors joined Viral Genetics' Board of Advisors in 2010, including Nobel Laureate Baruch S. Blumberg, MD, Ph.D. and biofuels expert John Sheehan. Dr. Blumberg is the discoverer of the Hepatitis B virus, and the inventor of the vaccine for it. The Company also retained two independent research firms, Zacks and Research 2.0 Partners, to research and write reports on the Company and its stock as a means of providing further exposure to Viral Genetics among the North American investment community.
About Viral Genetics, Inc.
San Marino, California-based Viral Genetics discovers drug therapies. Founded in 1994, the biotech company is researching treatments for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant tumors. A majority-owned subsidiary called VG Energy is dedicated to exploring biofuel and agricultural applications for one of the technologies in its licensed portfolio. For more information please visit www.viralgenetics.com.
About VG Energy, Inc.
VG Energy Inc. is an alternative energy and agricultural biotech company that is a majority-owned subsidiary of Viral Genetics Inc., a biotechnology company researching new treatments and methods of detection for diseases including cancer, HIV/AIDS and others. Using its Metabolic Disruption technology ("MDT"), Viral Genetics' cancer research led to discoveries with major consequences in a wide variety of other industries, including bio-fuel and vegetable oils. VG Energy Inc. holds the exclusive worldwide rights to the licensed MDT patents for us in the increase of production of various plant-derived oils from algae and seeds. Importantly, these pivotal discoveries promise to allow the biofuel industry to overcome its major obstacle in the area of production efficiency: namely an increase in production yields leading to feasible economic returns on investment allowing renewable biodiesel to be competitive with fossil fuels. For more information please visit www.vgenergy.net.
Contact: Haig Keledjian, Viral Genetics
T: (626) 334-5310
email: info@viralgenetics.com
SOURCE Viral Genetics, Inc.
.
VRAL - quick DD and serious accumulation suggested; check the subsidiaries..............
.
VRAL - quick DD and serious accumulation suggested..............
.
"..No extra charge. I still think others should back me up with calls and emails.
.
The MFMMMs will drop the price to 0.0001 to take out a stupid Market Order and get away with it if it's not immediately reported to one's brokerage.
Newbies can get killed in this game.
.
FYI: Finally got a call-back from ATCC. The CE matter is now in front of the corporate counsel and executive staff. Hopefully, they will address it with OTCmkts post haste.
Per Lee Iacocca, "..Lead, ..follow, ..or get out of the way......
.
Paraphrasing Gordon Gekko, "..Badgering is good........
.
If you are truly concerned with accuracy, that was a Progresso Soup advertisement.
The other firm is also spelled "Campbell's" to the best of my recollection.
.
I don't believe my post had anything to do with reported revenues, I was addressing the excess weight being put on an SOS filing.
No need to get terminally defensive; I'm Long here too - and expect great things. My point continues to be "if you're on the Pinks, then do what the Pinks requires to look good". You don't ignore problems, you fix them..!!!
.
Thanks for posting it the way it is. SOS filings are smoke in the wind to responsible investors; SEC filings are what counts in addition to reputable business practices - and dealing with what is needed today. Fixing the OTCMarket no-quote problem is something I hope they deal with very shortly as it is the current problem.
.
OBTW; check "rah-rah / whoopee" poster profiles. You'll find that many with less than 500 posts since their born-on date have shown up lately. It is quite likely that these are "spare pumper aliases" that are easily created on iHub by using multiple computer IPs. They are only used 'as required' to avoid the appearance of pimping for a MFMMM or B-D. OTCMarkets monitors such things and can be a reason for a CAVEAT EMPTOR rating if the company is not keeping them apprised of basic information - while manipulation is suspected.
If one is not part of the solution, then one may be part of the problem. "..C'est la guerre.....
.
Trust me, they now recognize my name when I call in. They are aware, but not acting on the problem with the dispatch that is truly needed.
That's why I have politely and repeatedly asked for all the other Longs help on this matter. It does MATTER, hence the PPS is not holding its highs.
.
It sure as hail doesn't help..... On top of the current weather and Egypt situation.
This is why the small details are rather critical. I.e.: put out the smoldering trash can today while calling in the big equipment to douse the other fires tomorrow.
.
You are incorrect. The powers at be simply need to make contact with OTCMarkets.com and provide minimal basic info to clear the CAVEAT rating. It would in no way affect their other efforts to get their OTC/NAZ situation worked out.
That's a quote from the folks at OTCMarkets as of yesterday and again today.
.
I continue to disagree. The company is on the Pinks, so they need to do what the Pink market requires - contact OTCMarkets.com and provide updates to company information like officers, address and phone verification, etc. When they move up to the OTCBB or NZ again, then they will have to play the Big Boy game.
What any company file with a SOS is basically worthless to the investment community. When not fully reporting, they need to at least make an effort to avoid having a bloody CAVEAT EMPTOR - NO QUOTE rating making them look bad. Trust me, you're not going to sway my opinion on this - I've been around this BS too long.
Long, Holding, Accumulating.
.
I've called and written all the appropriate parties regarding the OTCMarkets 'no quotes / CAVEAT EMPTOR' problem. Hopefully, others who understand the detrimental effect involved will join in the effort to get it resolved promptly.
.
Since they have a feduciary responsibility to us, I disagree. Hence, I think they should be contacted repeatedly until they adequately respond.
.